HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Emedastine

HCID 3219
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
87233-61-2
Standard SMILES
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21
InChIKey
KBUZBQVCBVDWKX-UHFFFAOYSA-N
Molecular formula
C17H26N4O
Average molar mass
302.4 g/mol
Monoisotopic mass
302.21066145

Overview

Emedastine is 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis. It has a role as a H1-receptor antagonist, an anti-allergic agent and an antipruritic drug.

Names & identifiers

Preferred name
Emedastine
IUPAC
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
English name
Emedastine
Molecular formula
C17H26N4O
Molecular weight
302.41

Names & synonyms

emedastine87233-61-2EmedastinaEmedastinum1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole9J1H7Y9OJV1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazoleCHEBI:4779DTXSID70482431-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-
Show more names
EmestineEmedastine impurity FEmedastinc Impurity CEmedastine Impurity CEmedastine Impurity 14Emedastine, 10 mM in DMSO1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole
KG 24131-(2-(ethoxy)ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole1-(2-Ethoxy-ethyl)-2-(4-methyl-(1,4)diazepan-1-yl)-1H-benzoimidazoleRefChem:590745DTXCID8028218S01GX06Emedastine [INN]Emedastinum [INN-Latin]

Properties

Computed structural propertiesFilling in

XLogP
2.2
Topological polar surface area
33.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
5
Heavy atoms
22
Formal charge
0
Complexity
341

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.6
Solubility · 2 items

Soluble (difumarate formulation)

1.44e+00 g/L

Human Drugs · 2 items

Breast Feeding; Lactation; Milk, Human; Antihistamines

EMA approved medicines: Human medicine

Physical DescriptionSolid

Physicochemical properties

Boiling point
446.6 · 446.6±55.0 °C(Predicted)
Density
1.15 · 1.15±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C
solubility
125 mg/mL · DMSO: 125 mg/mL (413.35 mM); Ethanol: 100 mg/mL (330.68 mM)
pka
8.86 · 8.86±0.10(Predicted)
form
Viscous Liquid

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Chemistry & industry

Pharmacology

ATC Code · 3 items

S01GX06

S - Sensory organs

QS - Sensory organs

PharmacodynamicsEmedastine is a relatively selective H<sub>1</sub>-receptor antagonist.
Mechanism of Action · 1 item

Emedastine is a relatively selective, histamine H<sub>1</sub> antagonist. In vitro examinations of emedastine's affinity for histamine receptors demonstrate relative selectivity for the H<sub>1</sub> histamine receptor. In vivo studies have shown concentration-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Emedastine appears exert negligible effects on adrenergic, dopaminergic and serotonin receptors.

Biological Half-LifeThe elimination half-life in the plasma is 3-4 hours following oral administration.
Metabolism/MetabolitesTwo primary metabolites, 5-hydroxyemedastine and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms. Minor metabolites include the 5'-oxoanalogs of 5-hydroxyemedastine and 6-hydroxy-emedastine and the N-oxide.
FDA Pharmacological Classification · 5 items

9J1H7Y9OJV

EMEDASTINE

Mechanisms of Action [MoA] - Histamine H1 Receptor Antagonists

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Inhibitor

Emedastine is a Histamine-1 Receptor Inhibitor. The mechanism of action of emedastine is as a Histamine H1 Receptor Antagonist.

MeSH Pharmacological Classification · 2 items

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Related reactions

10 records
New reaction record
HRID 149394 reaction equation
HRID 149394As reactant
HRID 197660 reaction equation
HRID 197660As product
HRID 637016 reaction equation
HRID 637016As product
HRID 637017 reaction equation
HRID 637017As reactant
HRID 1388162 reaction equation
HRID 1388162As product
HRID 1546942 reaction equation
HRID 1546942As productAs reactant
HRID 1584426 reaction equation
HRID 1584426As product
HRID 1584427 reaction equation
HRID 1584427As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
87233-61-2
PubChem CID
3219
DTXSID
DTXSID7048243
ChEMBL
CHEMBL594
ChEBI
CHEBI:4779
UNII
9J1H7Y9OJV
Nikkaji
J253.163A
color
Yellow to brown
CAS DataBase Reference
87233 · 87233-61-2(CAS DataBase Reference)
FDA UNII
9 J1H7Y9OJV · 9J1H7Y9OJV
ATC code
1 GX06 · S01GX06

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2 items

Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.

Following oral administration, approximately 44% of the total dose can be recovered in the urine over the 24-hour period, with only 3.6% of the dose excreted as unchanged form. Two primary metabolites, 5- and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms.

Cellular LocationsMembrane
Metabolite PathwaysEmedastine H1-Antihistamine Action

Applications

UsesAntihistaminic, H1-receptor; asthma prophylactic; anti-allergic.

Upstream & downstream products

Upstream raw materials

N-(2-Ethoxy-ethyl)-benzene-1,2-diamine(2-Ethoxy-ethyl)-(2-nitro-phenyl)-amineEMEDASTINE IMPURITY E1-(2-Ethoxy-ethyl)-1,3-dihydro-benzoimidazol-2-one1H-Benzimidazole,2-chloro-1-(2-ethoxyethyl)1-Boc-hexahydro-1,4-diazepineN-Methylhomopiperazine2-ChlorobenzimidazoleAnilineFormaldehyde2-Nitrochlorobenzene
Additional notes · 1 item

DefinitionChEBI: 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the ifumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.